|
1
|
Report of an international working group to standardize response criteria for myelodysplastic syndromes.
|
Blood
|
2000
|
6.27
|
|
2
|
Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
|
N Engl J Med
|
1995
|
2.85
|
|
3
|
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.
|
J Clin Oncol
|
2001
|
2.71
|
|
4
|
Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON.
|
Lancet
|
1992
|
1.92
|
|
5
|
The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro.
|
Blood
|
1999
|
1.87
|
|
6
|
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.
|
Mult Scler
|
2006
|
1.70
|
|
7
|
Mutations in N-ras predominate in acute myeloid leukemia.
|
Blood
|
1987
|
1.68
|
|
8
|
Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.
|
Blood
|
2001
|
1.65
|
|
9
|
Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene.
|
Leukemia
|
2000
|
1.64
|
|
10
|
Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward.
|
J Clin Microbiol
|
1996
|
1.61
|
|
11
|
Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome.
|
Blood
|
2001
|
1.53
|
|
12
|
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.
|
Blood
|
2001
|
1.52
|
|
13
|
Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.
|
Blood
|
2000
|
1.46
|
|
14
|
Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
|
Leukemia
|
1999
|
1.44
|
|
15
|
[Diagnosis and treatment of non-Hodgkin lymphoma in Netherlands: variation in guidelines and in practice].
|
Ned Tijdschr Geneeskd
|
2000
|
1.39
|
|
16
|
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.
|
Br J Haematol
|
2001
|
1.38
|
|
17
|
Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation.
|
Mol Cell Biol
|
1993
|
1.38
|
|
18
|
Autologous hematopoietic stem cell transplantation for autoimmune diseases.
|
Bone Marrow Transplant
|
2005
|
1.37
|
|
19
|
Characterization of a human multilineage-colony-stimulating factor cDNA clone identified by a conserved noncoding sequence in mouse interleukin-3.
|
Gene
|
1987
|
1.30
|
|
20
|
Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia.
|
Blood
|
1998
|
1.29
|
|
21
|
Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia.
|
Proc Natl Acad Sci U S A
|
1994
|
1.25
|
|
22
|
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
|
Blood
|
1997
|
1.20
|
|
23
|
A method for cloning T-lymphocytic precursors in agar.
|
Am J Hematol
|
1979
|
1.20
|
|
24
|
Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital.
|
Emerg Infect Dis
|
2001
|
1.19
|
|
25
|
Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes.
|
Blood
|
1990
|
1.18
|
|
26
|
TRIADs: a new class of proteins with a novel cysteine-rich signature.
|
Protein Sci
|
1999
|
1.16
|
|
27
|
STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
|
Oncogene
|
2000
|
1.16
|
|
28
|
Clonogenic cells in acute myeloblastic leukemia.
|
Blood
|
1986
|
1.16
|
|
29
|
Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia.
|
Leukemia
|
2007
|
1.16
|
|
30
|
Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture.
|
Blood
|
1996
|
1.13
|
|
31
|
Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells.
|
Blood
|
2000
|
1.12
|
|
32
|
Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells.
|
Blood
|
1997
|
1.12
|
|
33
|
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
|
Leukemia
|
1997
|
1.10
|
|
34
|
Application of myeloid growth factors in the treatment of acute myeloid leukemia.
|
Leukemia
|
1997
|
1.09
|
|
35
|
Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia.
|
Blood
|
1990
|
1.08
|
|
36
|
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
|
Blood
|
1996
|
1.06
|
|
37
|
Somatostatin and the immune and haematopoetic system; a review.
|
Eur J Clin Invest
|
1994
|
1.04
|
|
38
|
The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML.
|
Leukemia
|
2012
|
1.02
|
|
39
|
Protein kinase C alpha controls erythropoietin receptor signaling.
|
J Biol Chem
|
2000
|
0.99
|
|
40
|
Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia.
|
Bone Marrow Transplant
|
2002
|
0.99
|
|
41
|
A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites.
|
Nucleic Acids Res
|
1997
|
0.98
|
|
42
|
Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis.
|
Eur J Clin Invest
|
1992
|
0.98
|
|
43
|
Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia.
|
Lancet
|
1981
|
0.98
|
|
44
|
A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform.
|
Blood
|
1995
|
0.98
|
|
45
|
The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation.
|
Blood
|
1996
|
0.96
|
|
46
|
Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome.
|
Blood
|
1997
|
0.94
|
|
47
|
Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
|
Leukemia
|
1993
|
0.94
|
|
48
|
Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.
|
Cancer Res
|
1978
|
0.93
|
|
49
|
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma.
|
Br J Haematol
|
1999
|
0.93
|
|
50
|
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice.
|
Leukemia
|
2000
|
0.93
|
|
51
|
Effects of fibroblasts on the growth of erythroid progenitor cells in vitro.
|
Exp Hematol
|
1977
|
0.92
|
|
52
|
A characterization of T lymphocyte colony-forming cells (TL-CFC) in human bone marrow.
|
Clin Exp Immunol
|
1980
|
0.92
|
|
53
|
Stimulating spectrum of human recombinant multi-CSF (IL-3) on human marrow precursors: importance of accessory cells.
|
Blood
|
1988
|
0.92
|
|
54
|
Flow cytometric differential of leukocyte populations in normal bone marrow: influence of peripheral blood contamination.
|
Cytometry B Clin Cytom
|
2008
|
0.91
|
|
55
|
Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).
|
Bone Marrow Transplant
|
1995
|
0.91
|
|
56
|
Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL.
|
Leukemia
|
1988
|
0.91
|
|
57
|
Specific involvement of tyrosine 764 of human granulocyte colony-stimulating factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes.
|
Blood
|
1996
|
0.91
|
|
58
|
Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
|
Leukemia
|
1996
|
0.90
|
|
59
|
Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor.
|
Blood
|
1999
|
0.89
|
|
60
|
Human AML colony growth in serum-free culture.
|
Leuk Res
|
1988
|
0.89
|
|
61
|
Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.
|
Hematol J
|
2001
|
0.89
|
|
62
|
Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia.
|
Blood
|
1989
|
0.89
|
|
63
|
Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes.
|
J Clin Invest
|
1991
|
0.88
|
|
64
|
Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis.
|
J Neurol Neurosurg Psychiatry
|
2006
|
0.88
|
|
65
|
ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells.
|
Leukemia
|
2005
|
0.88
|
|
66
|
MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.
|
Br J Haematol
|
1997
|
0.88
|
|
67
|
Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.
|
Leukemia
|
1995
|
0.88
|
|
68
|
Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2MDP liposomes.
|
Leukemia
|
1997
|
0.87
|
|
69
|
Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response.
|
Blood
|
1989
|
0.87
|
|
70
|
Myelodysplastic syndromes standardized response criteria: further definition.
|
Blood
|
2001
|
0.87
|
|
71
|
Different stimulative effects of human bone marrow and fetal liver stromal cells on erythropoiesis in long-term culture.
|
Blood
|
1987
|
0.86
|
|
72
|
The incidence of herpes zoster in patients with Hodgkin's disease. An analysis of prognostic factors.
|
Cancer
|
1985
|
0.86
|
|
73
|
Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice.
|
Leukemia
|
1995
|
0.86
|
|
74
|
The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors.
|
Blood
|
1987
|
0.86
|
|
75
|
Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
|
Leukemia
|
1994
|
0.86
|
|
76
|
Influence of genetic resistance and silica particles on survival after bone marrow transplantation.
|
Transplant Proc
|
1976
|
0.85
|
|
77
|
PHA-induced colony formation in acute non-lymphocytic and chronic myeloid leukemia.
|
Leuk Res
|
1980
|
0.85
|
|
78
|
Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and interleukin 2 stimulates in vitro colony formation.
|
Blood
|
1985
|
0.85
|
|
79
|
Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells.
|
Blood
|
1989
|
0.85
|
|
80
|
Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations.
|
Blood
|
1979
|
0.85
|
|
81
|
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
|
Bone Marrow Transplant
|
1999
|
0.84
|
|
82
|
Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor.
|
Leukemia
|
1990
|
0.84
|
|
83
|
Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells.
|
Blood
|
1991
|
0.84
|
|
84
|
The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11.
|
J Virol
|
1997
|
0.84
|
|
85
|
Rapid clearance of cytomegalovirus-specific IgG after repeated intravenous infusions of human immunoglobulin into allogeneic bone marrow transplant recipients.
|
J Infect Dis
|
1987
|
0.83
|
|
86
|
Mutant Wilms' tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD).
|
Leukemia
|
2009
|
0.83
|
|
87
|
Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia.
|
Blood
|
1996
|
0.83
|
|
88
|
Effects of human interleukin-3 on granulocytic colony-forming cells in human bone marrow.
|
Blood
|
1989
|
0.83
|
|
89
|
Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
|
Leukemia
|
1996
|
0.83
|
|
90
|
Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia.
|
Leukemia
|
1995
|
0.82
|
|
91
|
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin].
|
Ned Tijdschr Geneeskd
|
1995
|
0.82
|
|
92
|
Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis.
|
Rheumatol Int
|
1990
|
0.82
|
|
93
|
Human recombinant multilineage colony stimulating factor (interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro.
|
Blood
|
1987
|
0.82
|
|
94
|
The relevance of somatostatin receptor expression in malignant lymphomas.
|
Metabolism
|
1996
|
0.81
|
|
95
|
Splenectomy for the treatment of thrombotic thrombocytopenic purpura.
|
Br J Haematol
|
2005
|
0.81
|
|
96
|
No preferential sensitivity of clonogenic AML cells to ASTA-Z-7557.
|
Leuk Res
|
1984
|
0.81
|
|
97
|
On the maturation order of AML cells: a distinction on the basis of self-renewal properties and immunologic phenotypes.
|
Blood
|
1984
|
0.81
|
|
98
|
Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia.
|
J Clin Oncol
|
1988
|
0.81
|
|
99
|
Impaired iron uptake and transferrin binding by erythroblasts in the anaemia of rheumatoid arthritis.
|
Br J Rheumatol
|
1990
|
0.81
|
|
100
|
Interleukin-1 alpha also induces granulocyte-macrophage colony-stimulating factor in immature normal bone marrow cells.
|
Blood
|
1990
|
0.81
|
|
101
|
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.
|
Hematol J
|
2000
|
0.81
|
|
102
|
Somatostatin analogue scintigraphy of malignant lymphomas.
|
Br J Haematol
|
1993
|
0.81
|
|
103
|
Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route.
|
Blood
|
1996
|
0.81
|
|
104
|
Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release.
|
Blood
|
1989
|
0.80
|
|
105
|
Allogeneic bone marrow transplantation for primary myelofibrosis.
|
Br J Haematol
|
1992
|
0.80
|
|
106
|
Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
|
Br J Haematol
|
1996
|
0.80
|
|
107
|
Stimulation of proliferation and differentiation of acute myeloid leukemia cells on a bone marrow stroma in culture.
|
Exp Hematol
|
1985
|
0.80
|
|
108
|
A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative Group.
|
Leukemia
|
1999
|
0.80
|
|
109
|
Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts.
|
Blood
|
1990
|
0.80
|
|
110
|
Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells.
|
Blood
|
1993
|
0.80
|
|
111
|
Developments in T-cell depletion of allogeneic stem cell grafts.
|
Curr Opin Hematol
|
2000
|
0.80
|
|
112
|
Acute myeloid leukaemia with +i(12p) shortly after treatment of mediastinal germ cell tumour.
|
Br J Haematol
|
1994
|
0.80
|
|
113
|
Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors.
|
Leukemia
|
1991
|
0.80
|
|
114
|
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.
|
Blood
|
1997
|
0.80
|
|
115
|
High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study.
|
Ann Hematol
|
2006
|
0.79
|
|
116
|
Growth regulation of human acute myeloid leukemia: effects of five recombinant hematopoietic factors in a serum-free culture system.
|
Blood
|
1988
|
0.79
|
|
117
|
An assay for serum cytotoxicity against erythroid precursor cells in pure red cell aplasia.
|
Biomedicine
|
1977
|
0.79
|
|
118
|
Granulocyte-macrophage colony-stimulating factor receptors alter their binding characteristics during myeloid maturation through up-regulation of the affinity converting beta subunit (KH97).
|
J Biol Chem
|
1993
|
0.79
|
|
119
|
A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
|
Br J Haematol
|
1996
|
0.79
|
|
120
|
Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia.
|
Bone Marrow Transplant
|
1987
|
0.79
|
|
121
|
No stimulative effect of adipocytes on hematopoiesis in long-term human bone marrow cultures.
|
Blood
|
1983
|
0.79
|
|
122
|
Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.
|
Leukemia
|
1996
|
0.79
|
|
123
|
Pharmacokinetics of daunorubicin as a determinant of response in acute myeloid leukemia.
|
Haematol Blood Transfus
|
1987
|
0.79
|
|
124
|
Transplantation of fetal liver cells in the treatment of severe combined immunodeficiency disease.
|
Blut
|
1977
|
0.79
|
|
125
|
Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
|
Virology
|
2000
|
0.79
|
|
126
|
Membrane receptors for interleukin 2 on hematopoietic precursors in chronic myeloid leukemia.
|
Blood
|
1987
|
0.78
|
|
127
|
Interleukin 2 stimulates chronic lymphocytic leukemia colony formation in vitro.
|
Blood
|
1985
|
0.78
|
|
128
|
[Treatment results and the prognosis in patients with localization of non-Hodgkins-lymphoma in the central nervous system].
|
Ned Tijdschr Geneeskd
|
1998
|
0.78
|
|
129
|
Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant clone.
|
Leukemia
|
1997
|
0.78
|
|
130
|
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.
|
Leuk Lymphoma
|
1995
|
0.78
|
|
131
|
Maturation of human acute myeloid leukaemia in vitro: the response to five recombinant haematopoietic factors in a serum-free system.
|
Br J Haematol
|
1989
|
0.78
|
|
132
|
Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro.
|
Blood
|
1992
|
0.78
|
|
133
|
Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemia.
|
Br J Haematol
|
1998
|
0.78
|
|
134
|
Karyotypically distinct subpopulations in acute leukemia with specific growth requirements.
|
Blood
|
1982
|
0.78
|
|
135
|
Introduction of the human interleukin-6 (IL-6) receptor in murine IL-3-dependent hematopoietic cells restores responsiveness to IL-6.
|
Blood
|
1992
|
0.78
|
|
136
|
Patterns of acute myeloid leukemia colony growth in response to recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF).
|
Exp Hematol
|
1987
|
0.78
|
|
137
|
Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.
|
J Virol
|
1999
|
0.78
|
|
138
|
Clinical use of hematopoietic growth factors.
|
Rev Invest Clin
|
1994
|
0.78
|
|
139
|
[The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
|
Ned Tijdschr Geneeskd
|
2004
|
0.78
|
|
140
|
STAT3beta does not interfere with granulocyte colony-stimulating factor-induced neutrophilic differentiation.
|
Hematol J
|
2000
|
0.78
|
|
141
|
Post-remission treatment of acute myelogenous leukemia.
|
N Engl J Med
|
1995
|
0.78
|
|
142
|
Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123.
|
Hum Gene Ther
|
1996
|
0.77
|
|
143
|
Analysis of the TNF receptors on human leukaemia cells by affinity cross-linking.
|
Br J Haematol
|
1992
|
0.77
|
|
144
|
Density profiles and purification of chronic myeloid leukemia cells forming colonies in the PHA-leukocyte feeder assay.
|
Exp Hematol
|
1981
|
0.77
|
|
145
|
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group.
|
Blood
|
1989
|
0.77
|
|
146
|
Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
|
Leuk Res
|
1989
|
0.77
|
|
147
|
A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin.
|
Leuk Res
|
1986
|
0.77
|
|
148
|
Primary human acute myeloblastic leukaemia: an analysis of in vitro granulocytic maturation following stimulation with retinoic acid and G-CSF.
|
Br J Haematol
|
1991
|
0.77
|
|
149
|
Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
|
Leukemia
|
1993
|
0.77
|
|
150
|
T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants.
|
Bone Marrow Transplant
|
2006
|
0.77
|
|
151
|
In vivo uptake of daunorubicin by acute myeloid leukemia (AML) cells measured by flow cytometry.
|
Leukemia
|
1988
|
0.77
|
|
152
|
Incomplete chimerism in erythroid, myeloid and B lymphocyte lineage after T cell-depleted allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1988
|
0.77
|
|
153
|
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.
|
J Clin Oncol
|
1996
|
0.77
|
|
154
|
Etoposide, mitoxantrone and prednisone: a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin's lymphoma.
|
Haematologica
|
2000
|
0.77
|
|
155
|
Production of T lymphocyte colony-forming units from precursors in human long-term bone marrow cultures.
|
Blood
|
1984
|
0.77
|
|
156
|
Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line.
|
Leukemia
|
1997
|
0.77
|
|
157
|
An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture.
|
J Clin Invest
|
1998
|
0.77
|
|
158
|
P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy.
|
Leukemia
|
2000
|
0.77
|
|
159
|
Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
|
Leukemia
|
1993
|
0.76
|
|
160
|
Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
|
Exp Hematol
|
1989
|
0.76
|
|
161
|
Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
|
Leukemia
|
1990
|
0.76
|
|
162
|
Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5.
|
Leukemia
|
1991
|
0.76
|
|
163
|
Susceptibility of acute myeloid leukemia (AML) cells from clinically resistant and sensitive patients to daunomycin (DNR): assessment in vitro after stimulation with colony stimulating factors (CSFs).
|
Leuk Res
|
1990
|
0.76
|
|
164
|
Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein.
|
Semin Hematol
|
2001
|
0.76
|
|
165
|
Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy.
|
Genes Chromosomes Cancer
|
1999
|
0.76
|
|
166
|
Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II study.
|
Leukemia
|
1996
|
0.76
|
|
167
|
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.
|
J Clin Oncol
|
1997
|
0.76
|
|
168
|
Characterization of normal and regenerating bone marrow cells with a panel of monoclonal antibodies.
|
Scand J Haematol
|
1986
|
0.76
|
|
169
|
Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2.
|
Hematol J
|
2000
|
0.76
|
|
170
|
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative Group.
|
Haematol Blood Transfus
|
1990
|
0.76
|
|
171
|
GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF.
|
Leukemia
|
1998
|
0.76
|
|
172
|
Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).
|
Br J Haematol
|
2000
|
0.75
|
|
173
|
Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON).
|
Leukemia
|
1994
|
0.75
|
|
174
|
Induction of proliferation of haemopoietic stem cells in culture.
|
Exp Hematol
|
1977
|
0.75
|
|
175
|
Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells.
|
Leukemia
|
1990
|
0.75
|
|
176
|
[Management in paraproteinemia].
|
Ned Tijdschr Geneeskd
|
1992
|
0.75
|
|
177
|
Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial.
|
Pharmacoeconomics
|
1997
|
0.75
|
|
178
|
Fucose binding lectin for characterizing acute myeloid leukemia progenitor cells.
|
Blood
|
1986
|
0.75
|
|
179
|
Transplantation of non-purified autologous bone marrow in patients with AML in first remission.
|
Cancer
|
1984
|
0.75
|
|
180
|
Costs of introducing autologous BMT in the treatment of lymphoma and acute leukaemia in The Netherlands.
|
Bone Marrow Transplant
|
1995
|
0.75
|
|
181
|
Ultrasound examination of pathological cervical lymph nodes in patients with non-Hodgkin's lymphoma and Hodgkin's disease.
|
Br J Haematol
|
1994
|
0.75
|
|
182
|
EORTC Leukemia Group trials on acute myeloid leukemias: an overview.
|
Haematol Blood Transfus
|
1990
|
0.75
|
|
183
|
Heterogeneity of proliferative responses of human B cell precursor acute lymphoblastic leukemia (BCP-ALL) cells to interleukin 7 (IL-7): no correlation with immunoglobulin gene status and expression of IL-7 receptor or IL-2/IL-4/IL-7 receptor common gamma chain genes.
|
Leukemia
|
1995
|
0.75
|
|
184
|
Autologous stem-cell transplantation and purging.
|
J Clin Oncol
|
1996
|
0.75
|
|
185
|
The C-terminal cytoplasmic region of the granulocyte colony-stimulating factor receptor mediates apoptosis in maturation-incompetent murine myeloid cells.
|
Exp Hematol
|
1996
|
0.75
|
|
186
|
Leukemic karyotype in CFU-C of a patient with acute myelomonocytic leukemia.
|
N Engl J Med
|
1983
|
0.75
|
|
187
|
High-dose methotrexate with leucovorin rescue: effectiveness in relapsed hairy cell leukemia.
|
Blood
|
1985
|
0.75
|
|
188
|
Acute lymphoblastic leukemia and non-Hodgkin's lymphoma of T lineage: colony-forming cells retain growth factor (interleukin 2) dependence.
|
Blood
|
1986
|
0.75
|
|
189
|
Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
|
J Nucl Med
|
2001
|
0.75
|
|
190
|
A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1998
|
0.75
|
|
191
|
[Malignant disorders of the lymphatic system].
|
Ned Tijdschr Geneeskd
|
1986
|
0.75
|
|
192
|
Acute myeloid leukemia colony growth in vitro: differences of colony-forming cells in PHA-supplemented and standard leukocyte feeder cultures.
|
Blood
|
1982
|
0.75
|
|
193
|
Interleukin-3 (IL-3) receptors on rhesus monkey bone marrow cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF.
|
Exp Hematol
|
1994
|
0.75
|
|
194
|
Phase II study of lomustine, cytarabine, mitoxantrone, and prednisone (CAMP) combination chemotherapy for doxorubicin-resistant intermediate- and high-grade malignant non-Hodgkin's lymphoma.
|
Semin Oncol
|
1990
|
0.75
|
|
195
|
The value of a 51Cr platelet lysis assay as crossmatch test in patients with leukaemia on platelet transfusion therapy.
|
Br J Haematol
|
1986
|
0.75
|
|
196
|
Phenotyping of acute myelocytic leukemia (AML) progenitors: an approach for tracing minimal numbers of AML cells among normal bone marrow.
|
Leukemia
|
1988
|
0.75
|
|
197
|
Dexamethasone does not counteract the response of acute promyelocytic leukaemia cells to all-trans retinoic acid.
|
Br J Haematol
|
1999
|
0.75
|
|
198
|
Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
|
Leukemia
|
1993
|
0.75
|
|
199
|
Analysis of the breakpoints in translocation (15;17) observed in 4 patients with acute promyelocytic leukemia.
|
Hum Genet
|
1982
|
0.75
|
|
200
|
Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML.
|
Haematol Blood Transfus
|
1987
|
0.75
|
|
201
|
Haemopoietic growth factors in acute myeloblastic and lymphoblastic leukaemia.
|
Baillieres Clin Haematol
|
1992
|
0.75
|
|
202
|
Interleukin 2: its role in the proliferation of neoplastic T and B cells.
|
J Pathol
|
1986
|
0.75
|
|
203
|
Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes.
|
Leuk Res
|
1989
|
0.75
|
|
204
|
[AML-6 and AML-7 studies on the treatment of acute myelocytic leukemia. Cyclic alternating chemotherapy during remission, and induction of remission and survival of elderly patients].
|
Onkologie
|
1985
|
0.75
|
|
205
|
Somatostatin modulates G-CSF-induced but not interleukin-3-induced proliferative responses in myeloid 32D cells via activation of somatostatin receptor subtype 2.
|
Hematol J
|
2001
|
0.75
|
|
206
|
[New dimensions in the treatment of cancer?].
|
Ned Tijdschr Geneeskd
|
1980
|
0.75
|
|
207
|
[Bone marrow culture, a new method of study in hematology].
|
Ned Tijdschr Geneeskd
|
1978
|
0.75
|
|
208
|
Platelet transfusion and alloimmunization.
|
Blood
|
1982
|
0.75
|
|
209
|
[Developments in the treatment of patients with chronic myeloid leukemia].
|
Ned Tijdschr Geneeskd
|
1997
|
0.75
|
|
210
|
Eosinophilia and granulocytic dysplasia terminating in acute myeloid leukaemia after 24 years.
|
Br J Haematol
|
1996
|
0.75
|
|
211
|
[Myelodysplastic syndromes].
|
Ned Tijdschr Geneeskd
|
1987
|
0.75
|
|
212
|
Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentation.
|
Ann Hematol
|
1993
|
0.75
|
|
213
|
Variable differentiation of human acute myeloid leukaemia during colony formation in vitro: a membrane marker analysis with monoclonal antibodies.
|
Br J Haematol
|
1985
|
0.75
|
|
214
|
[Further developments in the treatment of acute myeloid leukemia with autologous bone marrow transplantation].
|
Ned Tijdschr Geneeskd
|
1987
|
0.75
|
|
215
|
Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease: more extended disease identified.
|
Br J Haematol
|
2001
|
0.75
|
|
216
|
Color-flow imaging sonography of portal and hepatic vein flow to monitor fibrinolytic therapy with r-TPA for veno-occlusive disease following myeloablative treatment.
|
Bone Marrow Transplant
|
1998
|
0.75
|
|
217
|
Somatostatin and its cyclic octapeptide analog SMS 201-995 as inhibitors of proliferation of human acute lymphoblastic and acute myeloid leukemia.
|
Leuk Res
|
1995
|
0.75
|
|
218
|
Induction of granulocytic maturation in acute myeloid leukemia by G-CSF and retinoic acid.
|
Leuk Res
|
1991
|
0.75
|
|
219
|
[Views on the financing of biomedical scientific research; the report 'Erop of eronder' (Sink or swim) from the KNAW (Royal Netherlands Academy of Arts and Sciences)].
|
Ned Tijdschr Geneeskd
|
2006
|
0.75
|
|
220
|
[Bone marrow transplantation in development].
|
Ned Tijdschr Geneeskd
|
1978
|
0.75
|
|
221
|
[AML-7 study of the value of intensive remission induction in aged patients with acute myelocytic leukemia].
|
Onkologie
|
1985
|
0.75
|
|
222
|
[Myelodysplastic syndromes: a group of preleukemic disorders].
|
Ned Tijdschr Geneeskd
|
1987
|
0.75
|
|
223
|
Comparative analysis of IL-1 regulated and spontaneous growth of acute myeloid leukemia in vitro.
|
Bone Marrow Transplant
|
1990
|
0.75
|
|
224
|
[Allogenic bone marrow transplantation in men].
|
Hamatol Bluttransfus
|
1975
|
0.75
|
|
225
|
Feeder cell requirements for leukemia cell colony formation in cultures supplemented with phytohemagglutinin.
|
Cancer Res
|
1984
|
0.75
|
|
226
|
[Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in patients with leukemia].
|
Ned Tijdschr Geneeskd
|
1986
|
0.75
|
|
227
|
Further results in understanding the subpopulation structure of AML: clonogenic cells and their progeny identified by differentiation markers.
|
Blood
|
1985
|
0.75
|
|
228
|
Treatment of patients with acute myeloid leukemia in first remission with marrow ablative therapy and autologous bone marrow transplantation.
|
Haematol Blood Transfus
|
1987
|
0.75
|
|
229
|
Concentrations of ciclosporin in allogeneic bone marrow recipients. Comparison of assay methods.
|
Blut
|
1987
|
0.75
|
|
230
|
CD20 and CD40 mediated mitogenic responses in B-lineage acute lymphoblastic leukaemia.
|
Br J Haematol
|
1996
|
0.75
|
|
231
|
High dose therapy for acute myelocytic leukemia treatment strategy: what is the choice?
|
Ann Oncol
|
1993
|
0.75
|
|
232
|
Role of interleukin-7 in the growth of acute lymphoblastic leukemia.
|
Bone Marrow Transplant
|
1990
|
0.75
|
|
233
|
Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation.
|
Br J Haematol
|
1987
|
0.75
|
|
234
|
In vitro colony growth of acute myelogenous leukemia.
|
Hamatol Bluttransfus
|
1976
|
0.75
|
|
235
|
The treatment of acute leukaemia in adults: a perspective.
|
Neth J Med
|
1987
|
0.75
|
|
236
|
Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2.
|
Leukemia
|
2001
|
0.75
|
|
237
|
Practical aspects and diagnostic significance of in vitro manipulation of progenitors in human acute myeloid and lymphoid leukaemia.
|
Baillieres Clin Haematol
|
1991
|
0.75
|
|
238
|
[Is aplastic anemia an autoimmune disease?].
|
Ned Tijdschr Geneeskd
|
1980
|
0.75
|
|
239
|
Retroviral transfer of the multidrug resistance-1 gene into lineage-committed and primitive hemopoietic cells.
|
Stem Cells
|
1995
|
0.75
|
|
240
|
Hematopoietic growth factor receptors: structure variations and alternatives of receptor complex formation in normal hematopoiesis and in hematopoietic disorders.
|
Leukemia
|
1995
|
0.75
|
|
241
|
Retinoic acid receptor fusion proteins: friend or foe.
|
Mol Cell Endocrinol
|
2000
|
0.75
|
|
242
|
Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia.
|
Br J Haematol
|
1996
|
0.75
|
|
243
|
Quantitative evaluation of intracellular uptake of daunorubicin in acute myeloid leukemia: a method analysis.
|
Cancer Chemother Pharmacol
|
1986
|
0.75
|
|
244
|
[Successful bone marrow transplantation in a patient with non-Hodgkin lymphoma of high-grade malignancy with invasion of the central nervous system].
|
Ned Tijdschr Geneeskd
|
1985
|
0.75
|
|
245
|
[STI571: a new dimension in the treatment of chronic myeloid leukemia].
|
Ned Tijdschr Geneeskd
|
2002
|
0.75
|
|
246
|
Phagocytic plasma cells in a patient with multiple myeloma.
|
Neth J Med
|
1995
|
0.75
|
|
247
|
Studies on chronic myeloid leukemia cell populations with colony-forming abilities in PHA-leukocyte feeder and Robinson assays.
|
Leuk Res
|
1982
|
0.75
|
|
248
|
In situ hybridization on May-Grünwald Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic abnormalities.
|
Blood
|
1993
|
0.75
|
|
249
|
Internalization-defective mutants of somatostatin receptor subtype 2 exert normal signaling functions in hematopoietic cells.
|
FEBS Lett
|
2001
|
0.75
|
|
250
|
[Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].
|
Ned Tijdschr Geneeskd
|
1997
|
0.75
|
|
251
|
Recombinant hematopoietic growth factors fail to induce a proliferative response in precursor B acute lymphoblastic leukemia.
|
Leukemia
|
1989
|
0.75
|
|
252
|
[Chronic benign neutropenia possibly caused by a plasma factor].
|
Tijdschr Kindergeneeskd
|
1986
|
0.75
|
|
253
|
Improved prognostic significance of cytokine-induced proliferation in vitro in patients with de novo acute myeloid leukemia of intermediate risk: impact of internal tandem duplications in the Flt3 gene.
|
Leukemia
|
2001
|
0.75
|
|
254
|
[Bacteriologic management of patients with decreased resistance].
|
Ned Tijdschr Geneeskd
|
1984
|
0.75
|
|
255
|
Treatment of acute myelocytic leukemia with low-dose cytosine arabinoside: results of a pilot study in four patients.
|
Leuk Res
|
1983
|
0.75
|
|
256
|
[Transplantation of autologous bone marrow in 3 patients with acute myeloid leukemia in first remission; initial experiences with a new treatment].
|
Ned Tijdschr Geneeskd
|
1983
|
0.75
|
|
257
|
Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
|
J Am Acad Dermatol
|
1996
|
0.75
|
|
258
|
Autologous bone marrow transplantation in first remission AML--its relative value.
|
Bone Marrow Transplant
|
1990
|
0.75
|
|
259
|
The prognostic significance of chromosomal findings in patients with acute myeloid leukemia in a study comparing the efficacy of autologous and allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1991
|
0.75
|
|
260
|
Quantitative aspects of fetal liver cell transplantation in animals and man.
|
Transplant Proc
|
1976
|
0.75
|
|
261
|
Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma.
|
Eur J Haematol
|
2002
|
0.75
|
|
262
|
Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II study.
|
Eur J Cancer Clin Oncol
|
1988
|
0.75
|
|
263
|
Detection of the blastic crisis cell clone in chronic myeloid leukaemia.
|
Br J Haematol
|
1985
|
0.75
|
|
264
|
Fatal cerebral toxoplasmosis in a bone marrow transplant recipient with leukemia.
|
Transplantation
|
1983
|
0.75
|
|
265
|
Cell to cell contact enhances the proliferation of acute myeloid leukemia (AML) cells in vitro without an apparent role of adhesion glycoproteins LFA1, MAC1 and P150-95.
|
Leuk Res
|
1989
|
0.75
|
|
266
|
Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome.
|
Blood
|
1992
|
0.75
|